The first New Jersey trial in the cases regarding injuries as a result of Johnson & Johnson’s Levaquin, which was once J&J’s third-largest selling product generating more than $1 billion in sales over eight years, began this week. The case is the third to go to trial since November.
The Levaquin cases allege that Johnson & Johnson knew about the possible damage the antibiotic could cause to tendons, but failed to properly warn patients. The company and its Ortho-McNeil-Janssen Pharmaceutical unit now face more than 2,600 claims in U.S. courts over the drug. In many cases, patients have suffered Achilles-tendon ruptures that left them unable to walk and require surgery.
In 2008, the U.S. Food and Drug Administration required all makers of antibiotics in Levaquin’s class to increase warnings about tendon ruptures after finding that the antibiotics increased the risk of tendon ruptures to three to four times that of the general population.
Messa & Associates is available to handle cases involving Achilles-tendon ruptures or other tendon injuries related to Levaquin. Our attorneys are experienced at have handled dozens of cases involving drugs and drug product injuries. Our attorneys have successfully pursued litigation and obtained verdicts and settlements for victims suffering from these injuries. If you or a loved one has taken the Johnson & Johnson drug Levaquin and suffered a tendon rupture, please contact us at 1-877-MessaLaw.
No comments:
Post a Comment